Laurel Wealth Advisors, Inc. Novartis Ag Transaction History

Laurel Wealth Advisors, Inc.

$1.01 Billion
Q4 2022

A detailed history of Laurel Wealth Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 17,911 shares of NVS stock, worth $1.76 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

17,911

Previous 18,125 1.18%

Holding current value

$1.76 Million

Previous $1.38 Million 17.92%

% of portfolio

0.16%

Previous 0.15%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $16,167 - $19,799	-214 Reduced 1.18%	17,911 $1.63 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $12,832 - $15,008	-172 Reduced 0.94%	18,125 $1.38 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $199,045 - $231,750	-2,472 Reduced 11.9%	18,297 $1.55 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $162,062 - $183,324	2,023 Added 10.79%	20,769 $1.82 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $49,653 - $54,904	623 Added 3.44%	18,746 $1.64 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $23,225 - $27,019	284 Added 1.59%	18,123 $1.48 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $19,860 - $21,936	-233 Reduced 1.29%	17,839 $1.63 Million
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $59,953 - $70,701	-718 Reduced 3.82%	18,072 $1.55 Million
Q4 2020 Mar 03, 2021	SELL	$78.07 - $94.43 $1,405 - $1,699	-18 Reduced 0.1%	18,790 $1.77 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $71,215 - $78,897	-867 Reduced 4.41%	18,808 $1.64 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $76,721 - $86,362	948 Added 5.06%	19,675 $1.72 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $6,713 - $9,405	95 Added 0.51%	18,727 $1.54 Million
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $421 - $476	-5 Reduced 0.03%	18,632 $1.76 Million
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $20,016 - $22,056	-234 Reduced 1.24%	18,637 $1.62 Million
Q1 2019 May 16, 2019	SELL	$75.32 - $86.15 $30,730 - $35,149	-408 Reduced 2.12%	18,871 $1.81 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $22,392 - $24,934	-304 Reduced 1.55%	19,279 $1.48 Million
Q3 2018 Nov 15, 2018	SELL	$66.94 - $77.43 $1.48 Million - $1.71 Million	-22,059 Reduced 52.97%	19,583 $1.69 Million
Q2 2018 Aug 20, 2018	BUY	$64.91 - $73.36 $1.36 Million - $1.54 Million	21,010 Added 101.83%	41,642 $3.14 Million
Q1 2018 May 16, 2018	SELL	$70.39 - $84.15 $21,680 - $25,918	-308 Reduced 1.47%	20,632 $1.67 Million
Q4 2017 Feb 15, 2018	BUY	$72.33 - $77.64 $149,289 - $160,248	2,064 Added 10.93%	20,940 $1.76 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $23,947 - $24,958	323 Added 1.74%	18,876 $1.62 Million
Q2 2017 Aug 15, 2017	BUY	N/A	18,553	18,553 $1.55 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.

Account

Laurel Wealth Advisors, Inc. Novartis Ag Transaction History